Skip to main content
. 2022 Jan 24;8:769508. doi: 10.3389/fmed.2021.769508

Table 3.

Responses on prioritising ventilator allocation regarding the underlying health condition of patients.

Factor Low priority (%) Equal priority (%) High priority (%) Mean (SD) 95% CI Median (IQR) Skewness
Obesity
      30 < BMI ≤35 2 (5.7) 19 (54.3) 14 (40.0) 0.3 (0.6) 0.1, 0.6 0 (0, 1) −0.3
      35 < BMI ≤40 8 (22.9) 18 (51.4) 9 (25.7) 0.0 (0.7) −0.2, 0.3 0 (0, 1) 0.0
      BMI >40 18 (51.4) 10 (28.6) 7 (20.0) −0.3 (0.8) −0.6, 0.0 −1 (−1, 0) 0.6
Pregnancy 0 (0.0) 4 (11.4) 31 (88.6) 0.9 (0.3) 0.7, 1.0 1 (1, 1) −2.3
Uncontrolled hypertension 8 (22.9) 16 (45.7) 11 (31.4) 0.1 (0.7) −0.3, 0.4 0 (−1, 1) −0.1
Ischemic heart disease 10 (28.6) 15 (42.8) 10 (28.6) 0.0 (0.8) −0.3, 0.3 0 (−1, 1) 0.0
Diabetes mellitus 13 (37.1) 9 (25.8) 13 (37.1) 0.0 (0.9) −0.3, 0.3 0 (−1, 1) 0.0
Chronic kidney disease 13 (37.1) 12 (34.3) 10 (28.6) −0.1 (0.8) −0.4, 0.2 0 (−1, 1) 0.2
Neurodegenerative diseases 25 (71.4) 5 (14.3) 5 (14.3) −0.5 (0.8) −0.8, −0.3 −1 (−1, 0) 1.1
Chronic respiratory failure 20 (57.2) 4 (11.4) 11 (31.4) −0.3 (0.9) −0.6, 0.1 −1 (−1, 1) 0.6
Organ transplantation 6 (17.1) 14 (40.0) 15 (42.9) 0.3 (0.7) 0.0, 0.5 0 (0, 1) −0.5
Immunosuppressive use 7 (20.0) 15 (42.9) 13 (37.1) 0.2 (0.8) −0.1, 0.4 0 (0, 1) −0.3
HIV/AIDS 10 (28.6) 19 (54.3) 6 (17.1) −0.1 (0.7) −0.4, 0.1 0 (−1, 0) 0.1
Hepatic failure 20 (57.2) 6 (17.1) 9 (25.7) −0.3 (0.9) −0.6, 0.0 −1 (−1, 1) 0.7
Active malignancy 27 (77.1) 3 (8.6) 5 (14.3) −0.6 (0.7) −0.9, −0.4 −1 (−1, −1) 1.7